Profile
Simon Mangcwatywa is currently the Chief Executive Officer at Sizwe Medical Fund since 2018.
Prior to this, he worked as the Medical Director at Adcock Ingram Holdings Ltd., Head-Scientific Operations at Novartis SA, and Head-Medical Affairs & Business Development at Litha Pharma (Pty) Ltd.
Simon Mangcwatywa active positions
| Companies | Position | Start |
|---|---|---|
Sizwe Medical Fund
Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Chief Executive Officer | 2017-12-31 |
Former positions of Simon Mangcwatywa
| Companies | Position | End |
|---|---|---|
Litha Pharma (Pty) Ltd.
Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices | Corporate Officer/Principal | - |
Novartis SA
Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Corporate Officer/Principal | - |
| ADCOCK INGRAM HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Novartis SA
Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Health Technology |
Adcock Ingram Holdings Ltd.
Adcock Ingram Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, markets & sells branded and generic prescription and over-the-counter pharmaceutical | Health Technology |
Litha Pharma (Pty) Ltd.
Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices | Health Technology |
Sizwe Medical Fund
Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
- Stock Market
- Insiders
- Simon Mangcwatywa
















